Ledger.
Investor · London, United Kingdom

Parent of the General Partner Richard Impax Asset Management Group PLC

Open Parent in the network graph →
Filings
17
SEC Form D
Connections
58
co-filers
Capital
$100.4M
across filings
Active
Mar 2021
to Sep 2025

Most-connected co-filers (58)

Bruce R. Jenkyn-Jones · London, United Kingdom15 sharedKen Johnson · Mt. Laurel, NJ12 sharedJohn P. Mccarthy · Chicago, IL10 sharedJustin J. Dennis · Jacksonville, FL10 sharedBrett Novey · Chicago, IL10 sharedPatrick P. Unzicker · Chicago, IL10 sharedJeff Spain · Rialto, CA10 sharedEdward Shehwen · Mt. Laurel, NJ10 sharedAndrew T. Messer · Jacksonville, FL10 sharedStephen P. Schuler · Chicago, IL10 sharedRafael La Porta De Castro · Rialto, CA10 sharedJonathon B. Husby · Pleasanton, CA9 sharedMark Mccurdy, M.D · Fort Worth, TX9 sharedBernd B. Gottschalk · Pleasanton, CA9 sharedMatthew Fisch · Pleasanton, CA9 sharedJames P. Barry · Chicago, IL9 sharedJeff N. Lucassen · Toronto, Ontario, Canada9 sharedLori P. Richards · Chicago, IL9 sharedRobert P. Mcqueen · Chicago, IL9 sharedJohn P. Lord · Chicago, IL9 sharedJeff Mcdermott · Fargo, ND9 sharedKatherine N. Gurney · Toronto, Ontario, Canada9 sharedIan Balina · Potomac, MD9 sharedIan R. Simm · London, United Kingdom7 shared

Recent filings (17)

Impax Global Opportunities Fund L.P.Sep 2025 · 17 co-filersImpax Global Opportunities Fund L.P.Feb 2025 · 17 co-filersPharmaCann Inc.Apr 2024 · 23 co-filers$18.0MPharmaCann Inc.Apr 2024 · 23 co-filers$5.0MPharmaCann Inc.Apr 2024 · 23 co-filers$10.0MPharmaCann Inc.Apr 2024 · 23 co-filers$27.7MPharmaCann Inc.Apr 2024 · 23 co-filers$50.0MPharmaCann Inc.Apr 2024 · 23 co-filers$10.0MPharmaCann Inc.Apr 2024 · 23 co-filers$7.0MImpax Global Opportunities Fund L.P.Feb 2024 · 17 co-filersPharmaCann Inc.Apr 2023 · 29 co-filers$9.0MImpax Global Opportunities Fund L.P.Feb 2023 · 17 co-filersPharmaCann Inc.Nov 2022 · 29 co-filers$25.0MImpax Global Opportunities Fund L.P.Feb 2022 · 17 co-filersCytonus Therapeutics, Inc.Feb 2022 · 11 co-filers$1.0MPharmaCann Inc.Mar 2021 · 15 co-filers$33.0MCytonus Therapeutics, Inc.Mar 2021 · 11 co-filers$5.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Parent in the interactive graph →